Morning Buzz: Aerie Pharmaceuticals (AERI), Cablevision Systems (CVC), Oracle (ORCL), Expedia (EXPE)
September 17, 2015 at 09:20 AM EDT
Shares of drug developer Aerie Pharmaceuticals, Inc. (AERI) are spiking more than 97% ahead of the bell on news of successful results of its experimental drug Rhopressa being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. Aerie said the trial achieved its primary efficacy endpoint demonstrating non-inferiority […] View the full post at: Morning Buzz: Aerie Pharmaceuticals (AERI), Cablevision Systems (CVC), Oracle (ORCL), Expedia (EXPE) Related posts: Oracle (ORCL): Finally Bitten Off More than it Can Chew? Oracle (ORCL) Looks Downright Visionary Oracle Makes New Post Tech-Bubble Highs